Systemic metabolic alterations and their relationship to neuropsychiatric symptomatology PAIS, including long COVID, as well as CFS and IMD, share the characteristic of systemic metabolic disturbances, which may be a sign of underlying multi-organ inflammation and exhaustion [31], and consequently may contribute to neuropsychiatric symptomatology, as many metabolites can cross the bloodbrain barrier (BBB) [30, 58] (e.g., short chain fatty acids (SCFAs) derived from the gut microbiota such as acetate [40], amino acids such as tryptophan [52] and also carnitine/acetylcarnitine can cross the BBB via transporters [59])
En gnral, lorsque vous prenez un supplment qui n'est pas biodisponible, une grande partie de sa valeur est perdue avant qu'il n'atteigne vos cellules, car il se dcompose dans le systme digestif
Thanks for posting this
Vitamin B12 deficiency in infancy as a cause of developmental regression
Hair thinning is a side effect that some people experience while taking GLP-1 medications like semaglutide or tirzepatide